TrialMedicine2018

miR-17-92 cluster is connected with disease progression and oxaliplatin/capecitabine chemotherapy efficacy in advanced gastric cancer patients: A preliminary study.

Baohua Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.